Warning letter
The Standing Company: warning letter of May 7, 2013
FDA warning letter 396531 · Detroit District Office
Key facts
| Reference number | 396531 |
|---|---|
| Company | The Standing Company |
| Subject | CGMP/QSR/Medical Devices/Adulterated |
| Issue date | May 7, 2013 |
| Posted date | May 7, 2013 |
| Issuing office | Detroit District Office |
| Product type | Devices |
| CFR sections cited | 806, 820.3(b), 820 |
| Inspection city | Saginaw |
| Inspection ZIP | 48601 |
| Inspection start date | Mar 6, 2013 |
| Letter on fda.gov | web.archive.org |
At a glance
- 1–9 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: